Company intelligence / Profile preview

Sanakin BioScience

Germany
Ownership
Private
Development stage
Other
01

Overview

Sanakin BioScience has developed and commercialized the "Sanakin Technology," which enables the production of an autologous cytokine-rich serum from a patient's own blood. This technology is used for regulating inflammation and stimulating tissue regeneration in both human medicine (orthopedics, dermatology) and veterinary medicine. The company reports over 300,000 applications worldwide with more than 1,600 doctors using their therapies across 40+ countries as of 2022. Clinical results are described as encouraging in terms of safety/tolerability and efficacy for reducing inflammation and promoting healing/regeneration.

Therapeutic areas
DermatologyRheumatologyOther
Modalities
Autologous serum therapyBiologic (autologous cytokine-rich serum)
Industry
Biotech
02

Partnerships

Global distribution/trade partnerships in Europe, Asia, Middle East, America & Africa. Specific partners not named.

Beyond the preview

Go deeper on Sanakin BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanakin BioScience.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call